Biogen Pharmachem Industries Stock Performance
as on September 4, 2026 at 9:31 pm IST
Day's Low
₹0.27₹0.28
3.57%
Downside
52 Week's Low
52 Week's High
₹0.26₹0.80
7.14%
Downside
185.71%
Upside

Biogen Pharmachem Industries share price movements today
- Previous Close
- ₹0.28
- Open
- ₹0.28
- Volume
- 33.35L
- Upper Circuit
- ₹0.33
- Lower Circuit
- ₹0.23
- Day's Low - High
- ₹0.27 - ₹0.28
- 52 Week Low - High
- ₹0.26 - ₹0.80
Biogen Pharmachem Industries Historical Returns
- 1 Month Return
- -3.45 %
- 3 Month Return
- -17.65 %
- 1 Year Return
- -63.16 %
- 3 Year Return
- -58.21 %
- 5 Year Return
- -50.88 %
Biogen Pharmachem Industries Fundamentals
as on September 4, 2026 at 4:01 pm IST
Market Cap
₹29.49 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
14
Return on capital employed (ROCE)
0Industry PE ratio
24.56
Beta (LTM)
0P/B Ratio
1.12
Dividend Yield
0PEG Ratio
698.54
Quarterly Earnings Growth YOY
-83.58
EPS (TTM)
0Book Value
0Biogen Pharmachem Industries Stock Valuation
as on September 4, 2026 at 4:01 pm IST
Biogen Pharmachem Industries in the last 5 years
Lowest (-17788.94x)
July 24, 2025
Today (14.00x)
September 3, 2026
Industry (24.56x)
September 3, 2026
Highest (182.00x)
February 11, 2022
Today’s Price to Earnings Ratio: 14.00x
Biogen Pharmachem Industries Technical Analysis
Track how Biogen Pharmachem Industries technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | |
CCI (20) | -54.32 | Neutral |
RSI (14) | 52.06 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 20.92 | Neutral |
Ultimate Oscillator (7,14,28) | 63.81 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 0.28 | Bullish |
EMA (20) | 0.28 | Bullish |
VWMA (20) | 0.28 | Bullish |
SMA (50) | 0.28 | Bullish |
EMA (50) | 0.28 | Bullish |
SMA (200) | 0.28 | Bullish |
EMA (200) | 0.28 | Bullish |
KAMA (200) | 0.28 | Bullish |
DEMA (200) | 0.28 | Bullish |
Biogen Pharmachem Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biogen Pharmachem Industries with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 29.49 | -10.18% | 0.00 | -1 | 1 | |
| NA | 22.82 | 41.71% | 0.00 | -1 | 2 | |
| NA | 9.52 | -10.1% | 0.00 | 2 | 3 | |
| NA | 124.58 | 390.92% | 0.00 | -1 | NA | |
| NA | 102.85 | 22.93% | 0.54 | 1 | 8 |
Biogen Pharmachem Industries Stock’s Investor Sentiment and Interest
Investment in Biogen Pharmachem Industries Ltd Shares on INDmoney has dropped by -8.45% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Biogen Pharmachem Industries Ltd Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Biogen Pharmachem Industries Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Biogen Pharmachem Industries Ltd Annual Profit & Loss
Figures in Rupees Crores
Biogen Pharmachem Industries Ltd Cash Flow
Figures in Rupees Crores
Biogen Pharmachem Industries Corporate Actions
View detailed summary of the earnings and dividend history of Biogen Pharmachem Industries.
Biogen Pharmachem Industries Ltd Earnings Results
Biogen Pharmachem Industries Ltd’s net profit fell -83.58% since last year same period to ₹0.22Cr in the Q1 2026-2027. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 161.11% jump in its net profits since last 3-months.
Read More about Earnings Results
Insights on Biogen Pharmachem Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 3 years, BSE Ltd has given 761.7% return, outperforming this stock by 819.9%
NO EFFECTAgainst Peers

In the last 1 year, BSE Ltd has given 47.0% return, outperforming this stock by 110.2%
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 6 months, Biogen Pharma stock has moved down by -49.1%
About Biogen Pharmachem Industries Ltd
Revenue: ₹0.44Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.22Cr as on June 2026 (Q1 FY27)
Chairperson Name: Niraj Vaghela
| Organisation | Biogen Pharmachem Industries Ltd |
| Industry | Finance |
| CEO | Niraj Vaghela |
| E-voting on shares | Click here to vote |
FAQs
What is Biogen Pharmachem Industries share price today?
Biogen Pharmachem Industries share price today stands at ₹0.28 as on at the close of the market. Biogen Pharmachem Industries share today touched a day high of ₹0.28 and a low of ₹0.27.
What is the 52 week high and 52 week low range for Biogen Pharmachem Industries share?
Biogen Pharmachem Industries touched a 52 week high of ₹0.8 and a 52 week low of ₹0.26. Biogen Pharmachem Industries share price today i.e. is closed at ₹0.28, which is -65.00% down from its 52 week high and 7.69% up from its 52 week low.
What is Biogen Pharmachem Industries's market capitalisation today?
Biogen Pharmachem Industries market capitalisation is ₹29.49 Cr as on .
How to buy Biogen Pharmachem Industries shares?
To buy Biogen Pharmachem Industries shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 531752 or Biogen Pharmachem Industries Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Biogen Pharmachem Industries shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Biogen Pharmachem Industries trading volume today?
Biogen Pharmachem Industries trading volume is 33.35L as on . This means that 33.35L shares of Biogen Pharmachem Industries were bought and sold on the stock market during today's trading session.